PhacoTreat
is a company dedicated to ophthalmology and the area of cataract surgery and
posterior capsular opacification (PCO),
sometimes called secondary cataract. This phenomenon affects all patients after
cataract surgery, of which 5 to 50% need to be treated by YAG-laser.
We are
developing an entirely new and patented concept for PCO-reduction,
a concept which will enable cataract surgeons to greatly reduce, and possibly
even eliminate, PCO. This is important since
it will reduce the need for YAG-laser treatment which
is potentially harmful for the retina, but it is also a prerequisite for the
new generation of accommodating injectible polymer
intraocular lenses.
Our aim is that
the first product, EpiLoop®, is launched in
the
A prospect of EpiLoop® was presented at ESCRS
Berlin, September 12-17. aiming at a deal before the
end of 2008. Additional
information about the product concept is presented at www.phacotreat.com/epiloop
|
Copyright
© 2008 PhacoTreat AB. All rights reserved. |